NCT03327883View on ClinicalTrials.gov

Retrospective Review of FDG PET MRI Management of Patients With Muscle Invasive Bladder Cancer

CompletedOBSERVATIONAL
Enrollment

15

Participants

Timeline

Start Date

October 26, 2017

Primary Completion Date

February 15, 2018

Study Completion Date

October 16, 2018

Conditions
Bladder Cancer
Trial Locations (1)

20892

National Cancer Institute (NCI), Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT03327883 - Retrospective Review of FDG PET MRI Management of Patients With Muscle Invasive Bladder Cancer | Biotech Hunter | Biotech Hunter